Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03502070 · ClinicalTrials.gov registry record · Phase 4
Human Factors Study to Validate the User Interface of TOBI Podhaler Using Placebo Capsules
A Phase 4 study, sponsored by Mylan.
- Completed
- Registry status
- Phase 4
- Development phase
- 47
- Enrollment target
NCT03502070 is a Phase 4 study that has completed, run by Mylan. The registered enrollment target is 47 participants.
The verdict
NCT03502070, a Phase 4 study, has completed, sponsored by Mylan.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 47 participants
- Enrollment target
Study Summary
The purpose of this study is to validate the user interface of TOBI Podhaler by establishing that the product can support safe and effective use for the intended users
Interventions
- DRUG Placebo
- DEVICE Tobi Podhaler
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 47 participants |
| Start Date | 2018-06-26 |
| Est. Completion | 2019-06-17 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03502070
The ClinicalTrials.gov registry entry for NCT03502070 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 47 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Mylan, which has 22 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT03502070 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03502070 about?
NCT03502070 is a clinical study titled "Human Factors Study to Validate the User Interface of TOBI Podhaler Using Placebo Capsules". The purpose of this study is to validate the user interface of TOBI Podhaler by establishing that the product can support safe and effective use for the intended users
What is the current status of trial NCT03502070?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 47 participants. The study started on 2018-06-26. Estimated completion is 2019-06-17.
What interventions are being tested in trial NCT03502070?
The interventions under investigation include: Placebo (DRUG), Tobi Podhaler (DEVICE).
Who is sponsoring clinical trial NCT03502070?
This trial is sponsored by Mylan, which has 22 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.